Sundrud Mark S, Torres Victor J, Unutmaz Derya, Cover Timothy L
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232-2605, USA.
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7727-32. doi: 10.1073/pnas.0401528101. Epub 2004 May 5.
Recent evidence indicates that the secreted Helicobacter pylori vacuolating toxin (VacA) inhibits the activation of T cells. VacA blocks IL-2 secretion in transformed T cell lines by suppressing the activation of nuclear factor of activated T cells (NFAT). In this study, we investigated the effects of VacA on primary human CD4(+) T cells. VacA inhibited the proliferation of primary human T cells activated through the T cell receptor (TCR) and CD28. VacA-treated Jurkat T cells secreted markedly diminished levels of IL-2 compared with untreated cells, whereas VacA-treated primary human T cells continued to secrete high levels of IL-2. Further experiments indicated that the VacA-induced inhibition of primary human T cell proliferation was not attributable to VacA effects on NFAT activation or IL-2 secretion. We show here that VacA suppresses IL-2-induced cell-cycle progression and proliferation of primary human T cells without affecting IL-2-dependent survival. Through the analysis of a panel of mutant VacA proteins, we demonstrate that VacA-mediated inhibition of T cell proliferation requires an intact N-terminal hydrophobic region necessary for the formation of anion-selective membrane channels. Remarkably, we demonstrate that one of these mutant VacA proteins [VacA-Delta(6-27)] abrogates the immunosuppressive actions of wild-type VacA in a dominant-negative fashion. We suggest that VacA may inhibit the clonal expansion of T cells that have already been activated by H. pylori antigens, thereby allowing H. pylori to evade the adaptive immune response and establish chronic infection.
近期证据表明,幽门螺杆菌分泌的空泡毒素(VacA)可抑制T细胞的激活。VacA通过抑制活化T细胞核因子(NFAT)的激活,阻断转化T细胞系中白细胞介素-2(IL-2)的分泌。在本研究中,我们调查了VacA对原代人CD4(+) T细胞的影响。VacA抑制通过T细胞受体(TCR)和CD28激活的原代人T细胞的增殖。与未处理的细胞相比,经VacA处理的Jurkat T细胞分泌的IL-2水平显著降低,而经VacA处理的原代人T细胞继续分泌高水平的IL-2。进一步实验表明,VacA诱导的原代人T细胞增殖抑制并非归因于VacA对NFAT激活或IL-2分泌的影响。我们在此表明,VacA抑制IL-2诱导的原代人T细胞的细胞周期进程和增殖,而不影响IL-2依赖的存活。通过对一组突变VacA蛋白的分析,我们证明VacA介导的T细胞增殖抑制需要完整的N端疏水区域,这是形成阴离子选择性膜通道所必需的。值得注意的是,我们证明这些突变VacA蛋白之一[VacA-Δ(6-27)]以显性负性方式消除野生型VacA的免疫抑制作用。我们认为,VacA可能抑制已被幽门螺杆菌抗原激活的T细胞的克隆扩增,从而使幽门螺杆菌逃避适应性免疫反应并建立慢性感染。